Table 3.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
Parameters | HR | IC 95% | p | HR | IC 95% | p |
Male sex | 2.682 | 1.195–6.019 | 0.017 | 4.095 | 1.614–10.386 | 0.003 |
Age | 0.988 | 0.958–1.020 | 0.462 | |||
Disease duration | 0.990 | 0.952–1.029 | 0.610 | |||
Digital ulcers | 1.052 | 0.542–2.042 | 0.881 | |||
mRSS | 0.989 | 0.942–1.038 | 0.658 | |||
ATA | 1.222 | 0.588–2.537 | 0.591 | |||
Late NVC pattern | 1.607 | 0.836–3.089 | 0.55 | |||
Significant ILD | 2.483 | 1.161–5.310 | 0.019 | 2.407 | 1.082–5.354 | 0.031 |
NYHA class III-IV | 2.261 | 1.261–5.446 | 0.010 | 0.735 | 0.232–2.335 | 0.602 |
Pericardial effusion | 1.821 | 0.849–3.908 | 0.124 | |||
TAPSE/sPAP <0.32 | 2.365 | 1.230–4.549 | 0.010 | 2.439 | 1.143–5.205 | 0.021 |
PVR >5 | 2.248 | 1.115–4.533 | 0.024 | 1.232 | 0.500–3.036 | 0.651 |
DLCO | 0.980 | 0.958–1.002 | 0.076 | |||
Cardiac Index | 0.677 | 0.166–1.176 | 0.166 | |||
BNP | 1.001 | 1.000–1.003 | 0.076 | |||
Serum urate elevation | 1.413 | 0.743–2.688 | 0.292 |
Bold values were statistically significant.